EFDID: 335046EFD: View Filing

Issuer: Aspargo Laboratories, Inc. (0001805092) - D/A

Accession: 0001753926-20-000209 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0001805092
  • Entity Name:
    Aspargo Laboratories, Inc.
  • Entity Type:
    Corporation
  • Jurisdiction:
    DELAWARE
  • Year of Inc:
    Within 5 years (2019)
  • Address:
    550 SYLVAN AVENUE, SUITE 102
    ENGLEWOOD CLIFFS, NJ 07632
  • Persons:
    Related Persons 3
    Michael Demurjian
    Executive Officer, Director, Promoter 
    Founder of the Company.
    Michael Rice
    Director
    Fred Biehl
    Director
EDGAR: Offering Information
  • Accession Date:
    07/28/2020
  • First Sale Date:
    02/05/2020
  • Offering Amount:
    $8,500,000
  • Amount Sold:
    $2,511,900
  • Amount Remaining:
    $5,988,100
  • Exemptions:
    Rule 506
  • Security Type(s):
    Equity
EFD: Current State Notices
View Notices

Notices found in EFD

Filed:CA, MA, MD, NC, NH, NJ, OH, PA
Inactive:CO, SC, TN, WV
EDGAR: Sales Compensation Recipient Information
RecipientCRDBroker DealerBD CRDStates
David Sukoff 4232120 Arq Advisors LLC 289499 CA, CO, FL, MD, MA, NH, NJ, NY, NC, OH, PA, SC, VT, WV
EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
Aspargo Laboratories, Inc./s/ Michael DemurjianMichael DemurjianChairman and CEO2020-07-28
Related EDGAR Submissions
Type Edgar Date EFD: Accession
D/A Oct. 15, 2020 335046: 0001753926-20-000335 Aspargo Laboratories, Inc.
Offer Amount: $8,500,000
Amount Sold: $7,900,000
Remaining: $600,000
D/A Jul. 28, 2020 335046: 0001753926-20-000209 Aspargo Laboratories, Inc.
Offer Amount: $8,500,000
Amount Sold: $2,511,900
Remaining: $5,988,100
D Mar. 03, 2020 335046: 0001753926-20-000030 Aspargo Laboratories, Inc.
Offer Amount: $8,500,000
Amount Sold: $235,000
Remaining: $8,265,000